Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection
Not Applicable
- Conditions
- Breast Cancer
- Interventions
- Device: Glubran 2
- Registration Number
- NCT02141373
- Lead Sponsor
- King Hussein Cancer Center
- Brief Summary
Glubran 2 as a surgical glue maybe effective in reducing seroma formation post axillary dissection in breast cancer patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 136
Inclusion Criteria
- The Patient should be above 18 years old
- The Patients has Node positive breast cancer
- The Patient is eligible for axillary dissection in addition to a surgical intervention for the primary tumor
- Patients whose sentinel lymph nodes test positive during surgery.
- The patient is willing to sign an informed consent to participation
Exclusion Criteria
- Platelet count is less than 100000
- Obese patients with a BMI of more than 35
- Patients who need immediate breast reconstruction surgery
- Patients who are receiving anticoagulation therapy or have coagulation disorders
- Pregnant or lactating patients
- Patients who are on steroid therapy
- Patients who received chest radiotherapy
- Patients who received neoadjuvant chemotherapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Glubran 2 Glubran 2 Glubran 2 will be used at end of surgery
- Primary Outcome Measures
Name Time Method Total seroma aspirate volume 3 months Total drainage volume 3 months
- Secondary Outcome Measures
Name Time Method Time to drain removal 3 months Adverse events 3 months Duration of fluid drainage 3 months Additional costs incurred due to the need of aspirations 3 months Number of seroma aspirations 3 months
Trial Locations
- Locations (1)
King Hussein Cancer Center
🇯🇴Amman, Jordan